title: Clinical pharmacology and first-time-in-man studies: the FDA levels the playing field.
authors.forename: J
authors.initials: J
authors.lastname: Luderer
authors.forename: A A
authors.initials: AA
authors.lastname: Piergies
authors.forename: D
authors.initials: D
authors.lastname: Jorkasky
authors.forename: A
authors.initials: A
authors.lastname: Sedman
authors.forename: S
authors.initials: S
authors.lastname: Reele
authors.forename: J
authors.initials: J
authors.lastname: Froehlich
authors.forename: J
authors.initials: J
authors.lastname: Cavanaugh
authors.forename: G L
authors.initials: GL
authors.lastname: Steinman
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D015507:Drugs, Investigational / Q000592:standards* / Q000627:therapeutic use; D005060:Europe; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D015507:Drugs, Investigational